LYNSEY SMITH: Open Payments
NPI 1437613031 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 12 payments from 8 companies in 2025. Trend: 2023 $193 · 2024 $153 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: AIRSUPRA, Kerendia, VRAYLAR, APTIMA, Ozempic, NUZYRA, FARXIGA, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
